Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 41 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 27 | 1,021−8%/yr | −8%/yr | 3.41.1× | 4% | 1,050 in 2030+0.5%/yr |
| Lumbar fusion | 24 | 953−1.6%/yr | −1.6%/yr | 3.21.1× | 2% | 760 in 2030−3.7%/yr |
| Cervical fusion & disc arthroplasty | 3 | 378−6.4%/yr | −6.4%/yr | 1.31.0× | 0% | 370 in 2030−0.3%/yr |
| Kyphoplasty & vertebroplasty | 0 | 169−17%/yr | −17%/yr | 0.60.6× | 32% | 230 in 2030+5.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 147 | 31,270+0.1%/yr | +0.1%/yr | 103.61.1× | 59% | 40,600 in 2030+4.4%/yr |
| Skin substitutes & wound grafts | 52 | 12,513+43%/yr | +43%/yr | 26.22.2× | 72% | 17,600 in 2030+5.9%/yr |
| Bone graft & orthobiologics | 5 | 186−18%/yr | −18%/yr | 0.60.8× | 0% | 150 in 2030−3.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 54 | 3,899−4.7%/yr | −4.7%/yr | 12.91.3× | 98% | 4,350 in 2030+1.8%/yr |
| Spinal cord & DRG stimulation | 6 | 353−6%/yr | −6%/yr | 1.12.0× | 95% | 380 in 2030+1%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 2 | 316−0.6%/yr | −0.6%/yr | 1.01.1× | 71% | 550 in 2030+9.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Dialysis access | 20 | 2,124−8.8%/yr | −8.8%/yr | 7.71.6× | 96% | 2,190 in 2030+0.5%/yr |
| Superficial venous ablation | 19 | 2,060−8.7%/yr | −8.7%/yr | 6.81.2× | 99% | 2,270 in 2030+1.7%/yr |
| Peripheral arterial intervention | 9 | 1,215−6.2%/yr | −6.2%/yr | 4.00.8× | 73% | 1,790 in 2030+6.7%/yr |
| Thrombectomy, IVC filters & venous stents | 3 | 412−4.7%/yr | −4.7%/yr | 1.41.2× | 0% | 540 in 2030+4.7%/yr |
| Carotid revascularization | 11 | 315−0.4%/yr | −0.4%/yr | 1.11.3× | 0% | 610 in 2030+11%/yr |
| Aortic endografts (EVAR/TEVAR) | 0 | 117−8%/yr | −8%/yr | 0.41.3× | 0% | 100 in 2030−2.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 24 | 1,609−1.2%/yr | −1.2%/yr | 6.01.0× | 0% | 1,850 in 2030+2.4%/yr |
| Cholecystectomy & appendectomy | 21 | 1,144−2.4%/yr | −2.4%/yr | 4.11.1× | 0% | 1,330 in 2030+2.6%/yr |
| Colorectal resection | 3 | 409−3.9%/yr | −3.9%/yr | 1.51.0× | 0% | 440 in 2030+1.1%/yr |
| Antireflux & hiatal hernia surgery | 2 | 177−7.6%/yr | −7.6%/yr | 0.60.9× | 0% | 200 in 2030+2.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 26 | 1,008−3.9%/yr | −3.9%/yr | 3.51.0× | 24% | 1,080 in 2030+1.2%/yr |
| BPH procedures | 22 | 901−13%/yr | −13%/yr | 3.10.7× | 60% | 1,050 in 2030+2.5%/yr |
| Incontinence, prolapse & sacral neuromodulation | 8 | 631−0.3%/yr | −0.3%/yr | 2.21.2× | 19% | 1,080 in 2030+9.3%/yr |
| Hysterectomy, hysteroscopy & ablation | 3 | 560−0.8%/yr | −0.8%/yr | 2.10.9× | 20% | 610 in 2030+1.5%/yr |
| Prostatectomy & nephrectomy | 4 | 227−1.5%/yr | −1.5%/yr | 0.90.7× | 0% | 510 in 2030+14%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 14 | 2,106−0.8%/yr | −0.8%/yr | 7.41.7× | 95% | 2,330 in 2030+1.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 22 | 1,149−6.4%/yr | −6.4%/yr | 4.30.7× | 53% | 1,270 in 2030+1.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 41 | 5,936+7.7%/yr | +7.7%/yr | 20.31.0× | 95% | 10,900 in 2030+11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 21 | 1,111−3%/yr | −3%/yr | 4.01.0× | 2% | 1,240 in 2030+1.8%/yr |
| EP ablation | 16 | 764+6.9%/yr | +6.9%/yr | 2.20.7× | 0% | 1,620 in 2030+13%/yr |
| LAA occlusion & loop recorders | 14 | 673+17%/yr | +17%/yr | 2.00.7× | 16% | 1,740 in 2030+17%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 41 | 1,817−3%/yr | −3%/yr | 5.11.1× | 0% | 1,970 in 2030+1.4%/yr |
| Structural heart (TAVR, TEER) | 30 | 487+4.8%/yr | +4.8%/yr | 1.40.9× | 0% | 610 in 2030+3.7%/yr |
| Mechanical circulatory support | 0 | 118−7.9%/yr | −7.9%/yr | 0.40.9× | 0% | 200 in 2030+9.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Aneurysm & intracranial embolization | 3 | 177+15%/yr | +15%/yr | 0.61.3× | 0% | 310 in 2030+9.8%/yr |
| Stroke thrombectomy | 3 | 133−3.3%/yr | −3.3%/yr | 0.51.2× | 0% | 190 in 2030+6.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 55 | 13,217−6.7%/yr | −6.7%/yr | 45.11.0× | 98% | 14,000 in 2030+1%/yr |
| Vitreoretinal surgery | 10 | 723−1.9%/yr | −1.9%/yr | 2.50.9× | 8% | 850 in 2030+2.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 98 | 24,594−2.4%/yr | −2.4%/yr | 89.00.8× | 70% | 25,500 in 2030+0.6%/yr |
| ERCP & endoscopic ultrasound | 10 | 659−2.7%/yr | −2.7%/yr | 2.30.7× | 0% | 610 in 2030−1.4%/yr |
| Bronchoscopy & lung nodule | 11 | 545+13%/yr | +13%/yr | 1.90.8× | 0% | 870 in 2030+8.2%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.